ImportRefusal LogoImportRefusal

Viatris, Inc.

⚠️ High Risk

FEI: 3011055092 • Canonsburg, PA • UNITED STATES

FEI

FEI Number

3011055092

📍

Location

Canonsburg, PA

🇺🇸
🏢

Address

1000 Mylan Blvd, , Canonsburg, PA, United States

High Risk

FDA Import Risk Assessment

63.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

10
Total Refusals
4
Unique Violations
11/10/2025
Latest Refusal
6/2/2015
Earliest Refusal

Score Breakdown

Violation Severity
78.5×40%
Refusal Volume
38.6×30%
Recency
96.2×20%
Frequency
9.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

758×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

1792×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

Refusal History

DateProductViolationsDivision
11/10/2025
64GDY29LEVONORGESTREL (ESTROGEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/24/2025
62OCA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/22/2023
62KDH08LOPERAMIDE HYDROCHLORIDE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
179AGR RX
Division of West Coast Imports (DWCI)
7/22/2022
62ACK03CALCITONIN, SALMON (ANTI-HYPERCALCEMIC)
118NOT LISTED
179AGR RX
Division of Northern Border Imports (DNBI)
10/8/2020
61LDY43PRASUGREL HYDROCHLORIDE (ANTI-COAGULANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/4/2018
66BCY99STIMULANT N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/14/2016
66VCB99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Florida District Office (FLA-DO)
9/14/2016
66VCB99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Florida District Office (FLA-DO)
9/9/2015
65VCB56ZOLPIDEM TARTRATE (SEDATIVE)
118NOT LISTED
27DRUG GMPS
75UNAPPROVED
Florida District Office (FLA-DO)
6/2/2015
66JCC01LEVOTHYROXINE SODIUM (THYROID HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Viatris, Inc.'s FDA import refusal history?

Viatris, Inc. (FEI: 3011055092) has 10 FDA import refusal record(s) in our database, spanning from 6/2/2015 to 11/10/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Viatris, Inc.'s FEI number is 3011055092.

What types of violations has Viatris, Inc. received?

Viatris, Inc. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Viatris, Inc. come from?

All FDA import refusal data for Viatris, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.